NCT06489470

Brief Summary

Decompressive hemicraniectomy (DC) is the standard procedure and life saving measure in case of malignant middle cerebral artery (MCA) infarction. However, there have been several studies reporting the neuroinflammatory cascade based on the necrotic tissue as one of the leading cause for the secondary brain damage, wherefore, strokectomy with resection of necrotic tissue has been proposed in some case series as an alternative surgical option. Thus, the aim of this study is to perform a pilot study by including patients with malignant MCA infarction and to check the feasibility of this specific surgical treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2024

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

June 26, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 8, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

July 8, 2024

Status Verified

July 1, 2024

Enrollment Period

10 months

First QC Date

June 26, 2024

Last Update Submit

July 2, 2024

Conditions

Keywords

necrosectomyalternative surgical treatmentstrokectomy

Outcome Measures

Primary Outcomes (1)

  • Rate of resurgery after necrosectomy of malignant MCA-infarction

    After the surgical treatment, the patients will be treated in the neurointensive care unit. During the clinical course, the necessity to perform a secondary surgery (e.g. hemicraniectomy) will be observed. For the safety of the patients, intracranial pressure monitoring will be continously performed as well.

    up to 2 weeks

Secondary Outcomes (2)

  • Surgical complications

    up to 3 months

  • Functional outcome via modified Rankin Scale (mRS; range 0-6; 0-3: favorable outcome, 4-6: unfavorable outcome) at 3 months

    up to 3 months

Study Arms (1)

Necrosectomy/Strokectomy

EXPERIMENTAL
Procedure: Strokectomy/Necrosectomy

Interventions

After obtaining CT-/MRT-perfusion, the infarcted area (e.g. infarct core) of malignant MCA-infarction is localized. By using the neuronavigation, surgical resection of necrotic tissue is performed in a non-eloquent area until the space occupying effect is released. At the end of the surgery, the bone flap is reinserted and fixated.

Necrosectomy/Strokectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Ischemic middle cerebral artery (MCA) infarction at least two thirds of the MCA territory
  • Clinical symptoms of acute unilateral MCA infarction less than 48 hours prior to the initiation of treatment

You may not qualify if:

  • Preexisting modified Rankin Scale \>2
  • Absence of pupillary reflexes or GCS \<6
  • Intracerebral hemorrhage or other associated brain lesions
  • Contraindications for surgery
  • Estimated life expectancy of less than 3 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Rostock

Rostock, Mecklenburg-Vorpommern, 18057, Germany

RECRUITING

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Sae-Yeon Won, MD

    Neurosurgery, University Medical Center Rostock

    PRINCIPAL INVESTIGATOR
  • Florian Gessler, MD PhD

    Neurosurgery, University Medical Center Rostock

    STUDY DIRECTOR
  • Matthias Wittstock, MD

    Neurology, University Medical Center Rostock

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 26, 2024

First Posted

July 8, 2024

Study Start

June 15, 2024

Primary Completion

March 31, 2025

Study Completion

June 30, 2025

Last Updated

July 8, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
Up to 12 months

Locations